Board of Directors

About

The board of directors at EvolveImmune Therapeutics is made up of experienced professionals from a variety of backgrounds. These include the Sr. Director - Global Program Leader, Microbiome at Takeda, Board Member at Arcellx, Inc., Board Member at Presage Biosciences, Inc., Board Member at Ribon Therapeutics, Senior Vice President - Global Head of Oncology & Hematology Drug Development at Genentech and Roche, Board Of Directors at CytomX Therapeutics, Director at Yale Cancer Ctr, Physician-in-Chief at Smilow Cancer Hospital, Board Member at eFFECTOR Therapeutics, Inc., Board Member at Mission Therapeutics, Board Member at FoRx Therapeutics, Vice President at Pfizer, President & CEO at Solasta Ventures, Partner at AJU IB Investment - US Office, Portfolio Manager, Healthcare Banking at RBS Citizens Bank, Research Associate at Berwind Private Equity, Assistant Professor at Yale University, Visiting Scientist at MIT, Visiting Postdoc at Broad Institute, Damon Runyon Cancer Research Fellow at MIT, Professor, Internal Medicine at Yale University/Yale Cancer Center, Vice President at Vion Pharmaceuticals, and Head, Biologics Evaluation Section, Investigational Drug Branch, CTEP at National Cancer Institute (NCI). These directors bring with them a wealth of knowledge and experience in fields such as biochemistry, finance, management, and cancer